| Prev Close: | 43.05 |
|---|---|
| Open: | 43.30 |
| Bid: | 42.91 x 800 |
| Ask: | 44.98 x 800 |
| 1y Target Est: | 38.00 |
| Beta: | 1.3 |
| Next Earnings Date: | N/A |
| Day's Range: | 43.06 - 43.88 |
|---|---|
| 52wk Range: | 24.84 - 43.88 |
| Volume: | 559,804 |
| Avg Vol (3m): | 492,541 |
| Market Cap: | 2.53B |
| P/E (ttm): | 34.09 |
| EPS (ttm): | 1.28 |
| Div & Yield: | N/A (N/A) |
Headlines
- Charles River Misses Estimates in 1QZacks(Thu 1:00PM EDT)
- Stocks In Give-Back Mode; Spirit Air Flies, MasterCard Offat Investor's Business Daily(Wed, May 1)
- PAREXEL International Management Discusses Q3 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 1)
- Today's Top Performers In Health Servicesat TheStreet(Wed, May 1)
- PAREXEL International Earnings Call scheduled for 10:00 am ET todayCCBN(Wed, May 1)
- PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Wed, May 1)
- PAREXEL Makes an Acquisitionat Motley Fool(Tue, Apr 30)
- Parexel International Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Tue, Apr 30)
- PAREXEL International Reports Third Quarter Fiscal Year 2013 ResultsPR Newswire(Tue, Apr 30)
- InPlay: PAREXEL announces acquisition of HERON Group for ~ $24 mlnBriefing.com(Tue, Apr 30)
- PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization ConsultancyPR Newswire(Tue, Apr 30)
- Q3 2013 PAREXEL International Earnings Release - After Market CloseCCBN(Tue, Apr 30)
- David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co. Inc., Interviews with The Wall Street Transcript: Opportunities in Hepatitis C and Genomic TechnologiesWall Street Transcript(Fri, Apr 26)
- PAREXEL Honored with 2013 "Partnership Pioneers of the Year" AwardPR Newswire(Wed, Apr 24)
- New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical IndustryPR Newswire(Mon, Apr 22)
Press Releases
- PAREXEL International Reports Third Quarter Fiscal Year 2013 ResultsPR Newswire(Tue, Apr 30)
- PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization ConsultancyPR Newswire(Tue, Apr 30)
- PAREXEL Honored with 2013 "Partnership Pioneers of the Year" AwardPR Newswire(Wed, Apr 24)
Reports
- PRXL: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 2)
- Trading Report for (PRXL). A detailed report, including free correlated market...Stock Traders Daily(May 2)
- ValuEngine Detailed Valuation Report for PRXLValuEngine, Inc.(May 2)
